Announced on its homepage: “Contraline Announcing: Contraline Raises $92.5M Series B to Advance the Future of Male Contraception → Pipeline NES/T ADAM Mission Team N…”.
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
Contraline is currently developing a novel male contraceptive. We call it Echo-V, the first non-surgical, non-hormonal, and reversible birth control for men.